181 related articles for article (PubMed ID: 18278567)
1. Effects of cell cycle inhibitors on tau phosphorylation in N2aTau3R cells.
Conejero-Goldberg C; Townsend K; Davies P
J Mol Neurosci; 2008 Jun; 35(2):143-50. PubMed ID: 18278567
[TBL] [Abstract][Full Text] [Related]
2. Microtubule destruction induces tau liberation and its subsequent phosphorylation.
Miyasaka T; Sato S; Tatebayashi Y; Takashima A
FEBS Lett; 2010 Jul; 584(14):3227-32. PubMed ID: 20561519
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments.
Schneider A; Biernat J; von Bergen M; Mandelkow E; Mandelkow EM
Biochemistry; 1999 Mar; 38(12):3549-58. PubMed ID: 10090741
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of 14-3-3z promotes tau phosphorylation at Ser262 and accelerates proteosomal degradation of synaptophysin in rat primary hippocampal neurons.
Qureshi HY; Han D; MacDonald R; Paudel HK
PLoS One; 2013; 8(12):e84615. PubMed ID: 24367683
[TBL] [Abstract][Full Text] [Related]
5. Stabilization of the cyclin-dependent kinase 5 activator, p35, by paclitaxel decreases beta-amyloid toxicity in cortical neurons.
Li G; Faibushevich A; Turunen BJ; Yoon SO; Georg G; Michaelis ML; Dobrowsky RT
J Neurochem; 2003 Jan; 84(2):347-62. PubMed ID: 12558997
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles.
Iqbal K; Alonso AC; Gong CX; Khatoon S; Pei JJ; Wang JZ; Grundke-Iqbal I
J Neural Transm Suppl; 1998; 53():169-80. PubMed ID: 9700655
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitination and abnormal phosphorylation of paired helical filaments in Alzheimer's disease.
Iqbal K; Grundke-Iqbal I
Mol Neurobiol; 1991; 5(2-4):399-410. PubMed ID: 1726645
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease.
An WL; Cowburn RF; Li L; Braak H; Alafuzoff I; Iqbal K; Iqbal IG; Winblad B; Pei JJ
Am J Pathol; 2003 Aug; 163(2):591-607. PubMed ID: 12875979
[TBL] [Abstract][Full Text] [Related]
9. Early phosphorylation of tau in Alzheimer's disease occurs at Ser-202 and is preferentially located within neurites.
Su JH; Cummings BJ; Cotman CW
Neuroreport; 1994 Nov; 5(17):2358-62. PubMed ID: 7533559
[TBL] [Abstract][Full Text] [Related]
10. Anthraquinones inhibit tau aggregation and dissolve Alzheimer's paired helical filaments in vitro and in cells.
Pickhardt M; Gazova Z; von Bergen M; Khlistunova I; Wang Y; Hascher A; Mandelkow EM; Biernat J; Mandelkow E
J Biol Chem; 2005 Feb; 280(5):3628-35. PubMed ID: 15525637
[TBL] [Abstract][Full Text] [Related]
11. Hyperphosphorylation of tau is mediated by ERK activation during anticancer drug-induced apoptosis in neuroblastoma cells.
Guise S; Braguer D; Carles G; Delacourte A; Briand C
J Neurosci Res; 2001 Feb; 63(3):257-67. PubMed ID: 11170175
[TBL] [Abstract][Full Text] [Related]
12. Tau phosphorylated at tyrosine 394 is found in Alzheimer's disease tangles and can be a product of the Abl-related kinase, Arg.
Tremblay MA; Acker CM; Davies P
J Alzheimers Dis; 2010; 19(2):721-33. PubMed ID: 20110615
[TBL] [Abstract][Full Text] [Related]
13. Prevention of isoproterenol-induced tau hyperphosphorylation by melatonin in the rat.
Wang XC; Zhang J; Yu X; Han L; Zhou ZT; Zhang Y; Wang JZ
Sheng Li Xue Bao; 2005 Feb; 57(1):7-12. PubMed ID: 15719129
[TBL] [Abstract][Full Text] [Related]
14. The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer's disease-like tau phosphorylation.
Jämsä A; Hasslund K; Cowburn RF; Bäckström A; Vasänge M
Biochem Biophys Res Commun; 2004 Jul; 319(3):993-1000. PubMed ID: 15184080
[TBL] [Abstract][Full Text] [Related]
15. Neurodegeneration and plasticity.
Arendt T
Int J Dev Neurosci; 2004 Nov; 22(7):507-14. PubMed ID: 15465280
[TBL] [Abstract][Full Text] [Related]
16. Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms.
Andorfer C; Kress Y; Espinoza M; de Silva R; Tucker KL; Barde YA; Duff K; Davies P
J Neurochem; 2003 Aug; 86(3):582-90. PubMed ID: 12859672
[TBL] [Abstract][Full Text] [Related]
17. Absence of abnormal hyperphosphorylation of tau in intracellular tangles in Alzheimer's disease.
Bondareff W; Harrington CR; Wischik CM; Hauser DL; Roth M
J Neuropathol Exp Neurol; 1995 Sep; 54(5):657-63. PubMed ID: 7666054
[TBL] [Abstract][Full Text] [Related]
18. Glycosylation of microtubule-associated protein tau: an abnormal posttranslational modification in Alzheimer's disease.
Wang JZ; Grundke-Iqbal I; Iqbal K
Nat Med; 1996 Aug; 2(8):871-5. PubMed ID: 8705855
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine 394 is phosphorylated in Alzheimer's paired helical filament tau and in fetal tau with c-Abl as the candidate tyrosine kinase.
Derkinderen P; Scales TM; Hanger DP; Leung KY; Byers HL; Ward MA; Lenz C; Price C; Bird IN; Perera T; Kellie S; Williamson R; Noble W; Van Etten RA; Leroy K; Brion JP; Reynolds CH; Anderton BH
J Neurosci; 2005 Jul; 25(28):6584-93. PubMed ID: 16014719
[TBL] [Abstract][Full Text] [Related]
20. HDAC6 mutations rescue human tau-induced microtubule defects in Drosophila.
Xiong Y; Zhao K; Wu J; Xu Z; Jin S; Zhang YQ
Proc Natl Acad Sci U S A; 2013 Mar; 110(12):4604-9. PubMed ID: 23487739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
